Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease

Renal Impairment in a “Real-Life” Cohort of Anticoagulated Patients With Atrial Fibrillation (Implications for Thromboembolism and Bleeding)

(2013) Vanessa Roldán et al.   AMERICAN JOURNAL OF CARDIOLOGY

Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease

(2013) Robert G. Hart et al.   CANADIAN JOURNAL OF CARDIOLOGY

More Evidence on an Abominable Pairing

(2013) Wolfgang C. Winkelmayer   CIRCULATION

Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)

(2013) S. J. Connolly et al.   EUROPEAN HEART JOURNAL

The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate

(2013) S. Ibrahim et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin

(2013) Mattias Wieloch et al.   THROMBOSIS RESEARCH

An Update on the Prognosis of Patients With Atrial Fibrillation

(2012) David D. McManus et al.   CIRCULATION

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

(2012) Jonas Bjerring Olesen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease

(2011) R. G. Hart et al.   Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease in Patients with Ischemic Stroke

(2011) Yuuko Tsukamoto et al.   Journal of Stroke & Cerebrovascular Diseases

Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs

(2011) J. KOOIMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

(2011) Charles A. Herzog et al.   KIDNEY INTERNATIONAL

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methods to evaluate renal function in elderly patients: a systematic literature review

(2010) G. Van Pottelbergh et al.   AGE AND AGEING

Patient Outcomes after Acute Pulmonary Embolism

(2009) Frederikus A. Klok et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: A secondary analysis

(2009) Ahmed H. Abdelhafiz et al.   CLINICAL THERAPEUTICS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

INR variability in atrial fibrillation: A risk model for cerebrovascular events

(2008) Philippe Amouyel et al.   European Journal of Internal Medicine

Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants

(2008) Y. VAN LEEUWEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS